Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

May 2011

20

ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ulipristal acetate to treat uterine fibroids in Japan

May 2011

19

ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ellaOne® in Japan

Février 2011

23

NorLevo® the First Emergency Contraceptive to Receive Marketing Approval

December 2010

20

HRA Pharma Enters into Agreement with Chemo to Commercialize Novel Emerg

December 2010

02

Shin Poong Pharma and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate in South Korea.

December 2010

01

HRA Pharma’s Emergency Contraceptive ella® Now Available in the U.S.

September 2010

20

ellaOne® now reimbursed in France.

September 2010

17

Erin Gainer, CEO of HRA Pharma, Recognized for Her Leadership Role in the Pharmaceutical Industry.

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?